VBI Vaccines is a pharmaceutical company that researches and develops novel vaccines for the treatment of cancer and infectious diseases.Read more
$ < 1M
VBI's revenue is the ranked 16th among it's top 10 competitors. The top 10 competitors average 226.1M. Over the last three quarters, VBI's revenue has decreased by 97%. Specifically, in Q4 2015's revenue was $ < 1M; in Q3 2015, it was $ < 1M; in Q2 2015, it was $ < 1M.